Literature DB >> 14504502

The cosmetic use of botulinum toxin.

Rod J Rohrich1, Jeffrey E Janis, Steven Fagien, James M Stuzin.   

Abstract

The approach to facial rejuvenation continues to evolve. For decades, the primary focus on rejuvenation has centered on modalities such as skin care, skin resurfacing, soft-tissue augmentation, and surgical intervention. A better understanding of the physiologic changes that occur with facial aging lends itself to new approaches and techniques that are mindful of the causes. As animation has shown to be a significant contributor to both the appearance of facial lines and soft-tissue malposition, there has been recent interest in chemodenervating agents and their applications in the field of facial rejuvenation. These agents, by and large, efface rhytides by selective and precise focal paralysis of the underlying facial musculature and, therefore, reduce or eliminate the prominence of the overlying rhytides. In addition, chemodenervation can serve as an adjunct for facial rejuvenation because of its influence on facial soft-tissue position and shape. Botulinum toxin, derived from Clostridium botulinum, is the most widely used agent; therefore, this new modality, its applications in cosmetic plastic surgery, and its applications to other areas will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504502     DOI: 10.1097/01.PRS.0000082208.37239.5B

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins.

Authors:  Hyun-Mi Oh; Joo Hyun Park; Dae Heon Song; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-12-24       Impact factor: 4.546

Review 2.  Use of Botulinum Neurotoxin in Ophthalmology.

Authors:  Emel Başar; Ceyhun Arıcı
Journal:  Turk J Ophthalmol       Date:  2016-12-01

3.  Botulinum toxin type A induces protective autophagy in human dermal microvascular endothelial cells exposed to an in vitro model of ischemia/reperfusion injury.

Authors:  Yanyu Shi; Huang Lin; Jiankun Cao; Chao Cui
Journal:  Exp Ther Med       Date:  2018-09-17       Impact factor: 2.447

4.  Diagnostic and Therapeutic Use of Botox for Breast Reconstruction.

Authors:  Irene T Ma; Pooja Yesantharao; Halley M Darrach; Jennifer G Seither; Hui He; Dung H Nguyen
Journal:  Arch Clin Med Case Rep       Date:  2021-10-29

Review 5.  Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature.

Authors:  Hélène Moron; Corine Gagnard-Landra; David Guiraud; Arnaud Dupeyron
Journal:  Toxins (Basel)       Date:  2021-05-17       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.